These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9674303)

  • 1. [Dyslipidemias in renal diseases: pathogenesis and treatment].
    Cuevas A; Maíz A; Arteaga A
    Rev Med Chil; 1998 Mar; 126(3):315-21. PubMed ID: 9674303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms and treatment of dyslipidemia of renal diseases.
    Toto RD; Vega GL; Grundy SM
    Curr Opin Nephrol Hypertens; 1993 Sep; 2(5):784-90. PubMed ID: 7922219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the aggressive management of hyperlipidemia in nephrotic syndrome mandatory?
    Keane WF; St Peter JV; Kasiske BL
    Kidney Int Suppl; 1992 Oct; 38():S134-41. PubMed ID: 1405364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Disturbances of lipid metabolism during nephrotic syndrome: physiopathology and treatment].
    Moulin B; Ollier J; Olmer M
    Nephrologie; 1992; 13(5):193-9. PubMed ID: 1470293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid abnormalities in chronic renal failure, nephrotic syndrome and dialysis.
    Kes P
    Acta Med Croatica; 2001; 55(4-5):177-86. PubMed ID: 12398021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic management].
    Vanzetto G; Fouque D; Moulin B; Halimi S; Kessler M; Bayle F
    Nephrologie; 2000; 21(7):383-92. PubMed ID: 11200619
    [No Abstract]   [Full Text] [Related]  

  • 7. Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatment.
    Tsimihodimos V; Dounousi E; Siamopoulos KC
    Am J Nephrol; 2008; 28(6):958-73. PubMed ID: 18612199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid disorders and cardiovascular risks in nephrology.
    Dairou F
    Nephrol Dial Transplant; 1998; 13 Suppl 4():30-3. PubMed ID: 9614662
    [No Abstract]   [Full Text] [Related]  

  • 9. Dyslipidemia and its management after renal transplantation.
    Andany MA; Kasiske BL
    J Nephrol; 2001; 14 Suppl 4():S81-8. PubMed ID: 11798152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of lipid abnormalities in patients with nephrotic syndrome/proteinuria: clinical implications.
    Warwick GL; Packard CJ
    Miner Electrolyte Metab; 1993; 19(3):115-26. PubMed ID: 8232098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P; Reiner Z; Brunetta B
    Lijec Vjesn; 2002; 124(11-12):372-7. PubMed ID: 12679979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperlipidemia in nephrotic syndrome].
    Heaf JG
    Ugeskr Laeger; 1991 Aug; 153(35):2414-6. PubMed ID: 1949240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of hyperlipidemia of kidney disease.
    Grundy SM
    Kidney Int; 1990 Mar; 37(3):847-53. PubMed ID: 2179614
    [No Abstract]   [Full Text] [Related]  

  • 14. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease.
    Kidney Disease Outcomes Quality Initiative (K/DOQI) Group
    Am J Kidney Dis; 2003 Apr; 41(4 Suppl 3):I-IV, S1-91. PubMed ID: 12671933
    [No Abstract]   [Full Text] [Related]  

  • 15. Dyslipidemia in chronic renal failure patients.
    Almeida AF; Gunjotikar RV; Chitalia V
    J Postgrad Med; 1994; 40(2):52-4. PubMed ID: 8737550
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dyslipidemias and nephropathies].
    Mioli V; Pacchiarotti P; Lombardo L; De Vizia L; Perilli A; Sprovieri G; Recchioni A; Marchesi V
    Minerva Med; 1975 Oct; 66(66):3449-53. PubMed ID: 1178135
    [No Abstract]   [Full Text] [Related]  

  • 17. Glomerular atherosclerosis.
    Moorhead JF; Brunton C; Varghese Z
    Miner Electrolyte Metab; 1997; 23(3-6):287-90. PubMed ID: 9387135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atherosclerosis and arteriosclerosis of the small vessels in chronic renal insufficiency and after transplantation: lipid factors].
    Boizel R
    Nephrologie; 2000; 21(7):329-32. PubMed ID: 11200602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kidney diseases associated with hyperlipidemia and its treatment].
    Aitio ML
    Duodecim; 1991; 107(16):1315-22. PubMed ID: 1365353
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of genetic factors on the pathogenesis of the dyslipidemias following kidney transplantation].
    Lerman Garber I
    Rev Invest Clin; 2002; 54(5):472-3. PubMed ID: 12587422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.